The FDA allows approved nicotine pouches to advertise that they’re less harmful than cigarettes.

US FDA

US FDA News Release, ‘FDA grants first-ever modified risk orders to eight smokeless tobacco products FDA concludes completely switching from cigarettes to these authorized products lowers certain health risks,’ October 2019.

In 2019 the US Food & Drug Administration (FDA) granted risk modified orders to eight Swedish-style nicotine products.

The products were given the right to advertise with the claim: “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.

The FDA came to this conclusion following an exhaustive scientific review, including long-term epidemiological studies. 

The FDA stated that the “available evidence does not demonstrate significant youth initiation of these products.”

According to the FDA’s statement, these pouches “will significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole.”